{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:03:09Z","timestamp":1772038989744,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR11RA251"],"award-info":[{"award-number":["22JR11RA251"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["19SYPYB-8"],"award-info":[{"award-number":["19SYPYB-8"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Secondary hyperparathyroidism (SHPT) is a common complication of Chronic kidney disease (CKD), which is mainly manifested by the overproduction of Parathyroid hormone (PTH), leading to multi-system pathologies such as calcium and phosphorus metabolism disorders, skeletal lesions, and cardiovascular diseases, which seriously affects the quality of life of patients. In recent years, the role of microRNAs (miRNAs) in the pathogenesis of SHPT has been gradually revealed, providing new research directions for diagnosing and treating the disease. miRNAs play an important role in the development of SHPT by regulating genes related to calcium-phosphorus metabolism, influencing the stability and translational efficiency of PTH mRNAs, and regulating the proliferation and apoptosis of parathyroid cells. miRNA-based gene therapy strategies (e.g., miRNA antagonists or mimics) have shown promising therapeutic effects in animal models, but their clinical translation still faces challenges such as targeted delivery and safety. This review aims to summarize the mechanistic roles of miRNA and the progress of research in SHPT studies to provide a theoretical basis for diagnosing and treating SHPT.<\/jats:p>","DOI":"10.1186\/s12882-025-04177-1","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:45:23Z","timestamp":1747752323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miRNAs in secondary hyperparathyroidism: literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Ziyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoukai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"4177_CR1","doi-asserted-by":"crossref","unstructured":"Hassan A, Khalaily N, Kilav-Levin R, et al. Molecular mechanisms of parathyroid disorders in chronic kidney disease. Metabolites. 2022;12(2).","DOI":"10.3390\/metabo12020111"},{"key":"4177_CR2","doi-asserted-by":"publisher","first-page":"1059828","DOI":"10.3389\/fendo.2022.1059828","volume":"13","author":"LX Zhang","year":"2022","unstructured":"Zhang LX, Zhang B, Liu XY, et al. Advances in the treatment of secondary and tertiary hyperparathyroidism. Front Endocrinol (Lausanne). 2022;13:1059828.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4177_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"key":"4177_CR4","doi-asserted-by":"crossref","unstructured":"Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13(6).","DOI":"10.2215\/CJN.10390917"},{"issue":"5","key":"4177_CR5","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/jcem.87.5.8492","volume":"87","author":"S Corbetta","year":"2002","unstructured":"Corbetta S, Lania A, Filopanti M, Vicentini L, Ballar\u00e9 E, Spada A. Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab. 2002;87(5):2201\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"4177_CR6","doi-asserted-by":"publisher","unstructured":"Ma Y, Shen N, Wicha MS, Luo M. The roles of the Let-7 family of MicroRNAs in the regulation of cancer stemness. Cells. 2021;10(9). https:\/\/doi.org\/10.3390\/cells10092415.","DOI":"10.3390\/cells10092415"},{"issue":"14","key":"4177_CR7","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/febs.15300","volume":"287","author":"R Kilav-Levin","year":"2020","unstructured":"Kilav-Levin R, Hassan A, Nechama M, et al. Post-transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism. Febs J. 2020;287(14):2903\u201313.","journal-title":"Febs J"},{"key":"4177_CR8","doi-asserted-by":"crossref","unstructured":"Hassan A, Khalaily N, Kilav-Levin R, et al. Dicer-Mediated mTORC1 signaling and parathyroid gland integrity and function. J Am Soc Nephrol 2024;35(9).","DOI":"10.1681\/ASN.0000000000000394"},{"issue":"9","key":"4177_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/genes11090989","volume":"11","author":"CH Melick","year":"2020","unstructured":"Melick CH, Jewell JL. Regulation of mTORC1 by upstream stimuli. Genes. 2020;11(9):989.","journal-title":"Genes"},{"issue":"22","key":"4177_CR10","doi-asserted-by":"publisher","first-page":"e70184","DOI":"10.1096\/fj.202401547RR","volume":"38","author":"N Khalaily","year":"2024","unstructured":"Khalaily N, Hassan A, Khream Y, Naveh-Many T, Ben-Dov IZ. The roles of mTORC1 in parathyroid gland function in chronic kidney disease-induced secondary hyperparathyroidism: evidence from male genetic mouse models and clinical data. Faseb J. 2024;38(22):e70184.","journal-title":"Faseb J"},{"key":"4177_CR11","doi-asserted-by":"crossref","unstructured":"Shilo V, Mor-Yosef Levi I, Abel R, et al. Let-7 and MicroRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism. J Am Soc Nephrol 2017;28(8).","DOI":"10.1681\/ASN.2016050585"},{"issue":"2","key":"4177_CR12","doi-asserted-by":"publisher","first-page":"e0170535","DOI":"10.1371\/journal.pone.0170535","volume":"12","author":"S Jeong","year":"2017","unstructured":"Jeong S, Oh JM, Oh KH, Kim IW. Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients. PLoS One. 2017;12(2):e0170535.","journal-title":"PLoS ONE"},{"issue":"12","key":"4177_CR13","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"M Friedrich","year":"2017","unstructured":"Friedrich M, Pracht K, Mashreghi MF, J\u00e4ck HM, Radbruch A, Seliger B. The role of the miR-148\/-152 family in physiology and disease. Eur J Immunol. 2017;47(12):2026\u201338.","journal-title":"Eur J Immunol"},{"key":"4177_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.06.010","volume":"90","author":"T Nakatani","year":"2016","unstructured":"Nakatani T, Chen T, Partridge NC. MMP-13 is one of the critical mediators of the effect of HDAC4 deletion on the skeleton. Bone. 2016;90:142\u201351.","journal-title":"Bone"},{"issue":"7","key":"4177_CR15","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1002\/jcb.26827","volume":"119","author":"V Mohanakrishnan","year":"2018","unstructured":"Mohanakrishnan V, Balasubramanian A, Mahalingam G, Partridge NC, Ramachandran I, Selvamurugan N. Parathyroid hormone-induced down-regulation of miR-532-5p for matrix metalloproteinase-13 expression in rat osteoblasts. J Cell Biochem. 2018;119(7):6181\u201393.","journal-title":"J Cell Biochem"},{"issue":"11","key":"4177_CR16","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1002\/jcp.29454","volume":"235","author":"D Malavika","year":"2020","unstructured":"Malavika D, Shreya S, Raj Priya V, et al. miR-873-3p targets HDAC4 to stimulate matrix metalloproteinase-13 expression upon parathyroid hormone exposure in rat osteoblasts. J Cell Physiol. 2020;235(11):7996\u20138009.","journal-title":"J Cell Physiol"},{"issue":"6","key":"4177_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2174\/1566524021666210830093232","volume":"22","author":"N Akshaya","year":"2022","unstructured":"Akshaya N, Srinaath N, Rohini M, Ilangovan R, Selvamurugan N. Parathyroid Hormone-regulation of Runx2 by MiR-290 for matrix Metalloproteinase-13 expression in rat osteoblastic cells. Curr Mol Med. 2022;22(6):549\u201361.","journal-title":"Curr Mol Med"},{"key":"4177_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fendo.2018.00267","volume":"9","author":"RG Erben","year":"2018","unstructured":"Erben RG. Physiological actions of fibroblast growth Factor-23. Front Endocrinol (Lausanne). 2018;9:267.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4177_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2017.03.043","volume":"100","author":"H Olauson","year":"2017","unstructured":"Olauson H, Mencke R, Hillebrands J-L, Larsson TE. Tissue expression and source of Circulating \u0391Klotho. Bone. 2017;100:19\u201335.","journal-title":"Bone"},{"issue":"5","key":"4177_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.amjms.2020.09.013","volume":"361","author":"M Xu","year":"2021","unstructured":"Xu M, Li H, Bai Y, et al. miR-129 blocks secondary Hyperparathyroidism-Inducing Fgf23\/\u03b1Klotho signaling in mice with chronic kidney disease. Am J Med Sci. 2021;361(5):624\u201334.","journal-title":"Am J Med Sci"},{"key":"4177_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4158\/EP10325.RA","volume":"17","author":"CS Landry","year":"2011","unstructured":"Landry CS, Ruppe MD, Grubbs EG. Vitamin D receptors and parathyroid glands. Endocr Pract. 2011;17:63\u20138.","journal-title":"Endocr Pract"},{"issue":"4","key":"4177_CR22","first-page":"509","volume":"42","author":"J Han","year":"2022","unstructured":"Han J, Li PT, Liu LD, et al. Screening of MiRNAs targeting vitamin D receptor and their effects on parathyroid hormone secretion in patients with secondary hyperparathyroidism. J South Med Univ. 2022;42(4):509\u201317.","journal-title":"J South Med Univ"},{"key":"4177_CR23","doi-asserted-by":"publisher","first-page":"1059369","DOI":"10.3389\/fphys.2022.1059369","volume":"13","author":"L Iamartino","year":"2022","unstructured":"Iamartino L, Brandi ML. The calcium-sensing receptor in inflammation: Recent updates. Front Physiol. 2022;13:1059369.","journal-title":"Front Physiol"},{"issue":"08","key":"4177_CR24","first-page":"1363","volume":"43","author":"LD Liu","year":"2023","unstructured":"Liu LD, Qian LY, Li PT, et al. MiR-301a-5p regulates parathyroid hormone secretion in secondary hyperparathyroidism: based on modulation of calcium-sensitive receptor expression. J South Med Univ. 2023;43(08):1363\u201370.","journal-title":"J South Med Univ"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04177-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04177-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:45:26Z","timestamp":1747752326000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04177-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4177"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04177-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}